Related Experiment Video
Updated: Jul 14, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
[A clinicoeconomic model of basic therapy for bronchial asthma]
Klinicheskaia Meditsina
|May 25, 2007
Summary
This study analyzed common bronchial asthma (BA) treatments in Russia. Fixed combinations of inhaled corticosteroids and long-acting beta2-agonists proved most effective and cost-efficient for patients.
Area of Science:
- Pulmonology
- Pharmacoeconomics
- Epidemiology
Context:
- Bronchial asthma (BA) management requires effective and economically viable treatment strategies.
- Pharmacoepidemiological studies are crucial for assessing real-world treatment outcomes.
- A large-scale study in Russia evaluated various basic therapy models for BA.
Purpose:
- To analyze the most prevalent basic therapy approaches for bronchial asthma.
- To assess different pharmacotherapy models based on clinical efficacy, exacerbation risk, resource utilization, and cost.
- To determine the most effective and cost-rational treatment strategies for BA in clinical practice.
Summary:
- A pharmacoepidemiological study involving 1362 patients across 34 Russian cities analyzed standard bronchial asthma therapies.
- Treatment models were evaluated using clinical data, symptom frequency, BA exacerbation risk, healthcare resource use, and treatment costs.
- Fixed-dose combinations of inhaled glucocorticosteroids and long-acting beta2-adrenostimulators demonstrated superior effectiveness and economic rationality in real-world settings.
Impact:
- Provides evidence-based recommendations for optimizing bronchial asthma pharmacotherapy.
- Highlights the economic benefits of specific combination therapies in managing BA.
- Informs public health policy and clinical guidelines for cost-effective asthma management.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
01:13Asthma III: Clinical Manifestations
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...